Home/Filings/4/0001209191-21-014477
4//SEC Filing

Chereau Frederic 4

Accession 0001209191-21-014477

CIK 0001664106other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 7:00 PM ET

Size

5.3 KB

Accession

0001209191-21-014477

Insider Transaction Report

Form 4
Period: 2021-02-23
Chereau Frederic
DirectorPresident, CEO
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-23+282,804282,804 total
    Exercise: $7.76Exp: 2031-02-23Common Stock (282,804 underlying)
Footnotes (1)
  • [F1]25% vests on 01/01/2022 and the remainder vests in equal monthly installments over the next 36 months.

Issuer

LogicBio Therapeutics, Inc.

CIK 0001664106

Entity typeother

Related Parties

1
  • filerCIK 0001640592

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 7:00 PM ET
Size
5.3 KB